Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors

Transfusion Medicine and Hemotherapy

Volumn 22, Issue 4, 1995, Pages 208-219

  Caspari, G ^a   Gerlich, W H ^a   Beyer, J ^b   Schmitt, H ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b DRK Blutspendedienst Niedersachsen ^*  (Germany)

Author keywords

Blood transfusion; EIA; HCV; RIBA; Seroconversion; epidemiology; specificity

Indexed keywords

ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; HEPATITIS C; HUMAN; MALE;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALGORITHMS; BLOOD DONORS; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMAN; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84939656057     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000223127     Document Type: Article

References (45)

1. Holzberger G. Seidl S. Peschke B. Scheuermann EH. Schoeppe W: Verminderung der Posttransfusions- Non-A-, Non-B-Hepatilis durch Anti-HCV-Screening: in Kretschmer V. Stangel W. Wiebede D (Hrsg): Transfusionsmedizin 1991/92. Beitr Infusionsther. Basel. Karger. 1992. vol 30. pp 46–48.
2. de Beenhouwer H. Verhaert H. Claeys H. Vermylen C: Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction. Vox Sang 1992:63:198–203.
3. Caspari G. Gerlich WH. Beyer J. Schmitt H: Variable results of first generation anti-HCV enzyme immunoassay during follow-up of blood donors. Vox Sang 1993:64:61–62.
4. Baath L. Widell A. Nordenfelt E: A comparison between one first generation and three second generation anti-HCV ELISAs: An investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction. J Virol Methods 1992:40:287–296.
5. Kleinmann S. Alter H. Busch M. Holland P. Tegtmeier G. Nelles M. Lee S. Page E. Wilber J. Polito A: Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992:32:805–813.
6. Kolho E: Specificity and sensitivity of first and second generation anti-HCV ELISA in a low prevalence population. Transfusion Med 1992:2:239–242.
7. Lee S. McHutchinson J. Francis B. DiNello R. Polito A. Quan S. Nelles M: Improved detection of antibodies to hepatitis C virus using a second generation ELISA. Adv Exp Med Biol 1992:312:183–189.
8. Polywka S. Kaars-Wiele P. Schroeter E. Mandler J. Laufs R: Detection of antibodies to HCV: Comparison of a c100-3 EIA and the 2nd generation EIA: in Kretschmer V. Stangel W. Wiebede D (Hrsg): Transfusionsmedizin 1991/92. Beitr Infusionsther. Basel, Karger, 1992, vol 30, pp 42–45.
9. Zala G. Havelka J. Wicki AN. Joller-Jemelka HI, Meier B, Schmid M. Bühler H: Hepatitis-C-Virus-Test der zweiten Generation und Polymerase-Keltenreaktion bei anti-c100-negativen Patienten mil chronischer Non-A-Non-B-I lepatilis, Schweiz Med Wochcnschr 1992:122:363–368.
10. Mathiesen UL, Karlsson E, Foberg U, Fryden A, Franzen L, Widell A, Bodemar G: Also with a restrictive transfusion policy, screening with anti-hepatitis C enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery. Scand J Gastroenterol 1993:28:581–584.
11. Zhang HY. Kuramoto IK. Mamish D. Sazama K. Holland PV. Zeldis IB: Hepatitis C virus in blood samples from volunteer donors. J Clin Microbiol 1993:31:606–609.
12. Skaug K. Li H, Jonasscn TO, Larsen J, Figenschau KJ: Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients. Vox Sang 1993:64:215–219.
13. Larsen J. Skaug K. Maeland A: Second generation anti-HCV tests predict infectivitt. Vox Sang 1992; 63:39–42.
14. Shev S, Foberg U, Fryden A, Herntodsson S, Lindh G, Lindholm A, Mansson AS, von Sydow M, Weiland O, Widell A, Norkrans G: Second generation hepatitis C ELISA antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors. Vox Sang 1993: 65:32–37.
15. Richtlinien zur Blutgruppenbestimmung und Blut-transfusion. Aufgestellt vom wissenschaftlichen Beirat der Bundesärztekammcr und vom Bundesgesundheitsamt. Überarbritete Fassung 1987. Köln. Deutscher Ärzteverlag. 1992.
16. Caspari G. Beyer H-J. Elbert G. Koerner K. Muß P. Schunter F-W. Uy A. Gerlich W. Thomssen R. Schmitt H: Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol 1989:27: 2067–2072.
17. Courcucé AM. Janot C: Development of screening and confirmation tests for antibodies to hepatitis C virus; in Reesink HW (ed): Hepatitis C Virus. Curr Stud Hematol Blood Transfusion. Basel. Karger. 1994, No. 61. pp 36–48.
18. Busch MP, Tobler L. Ouan S, Wilber JC, Johnson P, Polito A. Steane E, Zola A, Bahl C, Nelles M. Lee SR: A pattern of 5-1-1 and cl00-3 only on hepatitis C virus (HCV) recombinant immunoblot assay docs not reflect HCV infection in blood donors. Transfusion 1993:33:84–88.
19. Empfehlungen der Deutsehen Gesellschaft für Klinische Chemie: Z Klin Chem Biochem 1972:10:182.
20. Schlebusch H. Rick W, Lang H, Knedel M: Normbereiche der Aktivitäten klinisch wichtiger Enzyme. Dtsch Med Wochcnschr 1974:99:765–766.
21. Caspari G, Beyer J, Gerlich WH, Schmitt H: Geschlechts- und altersspezifische GPT-Grenzwerte bei Blutspendern; in Kretschmer V, Stangel W, Wiebede D (Hrsg): Transfusionsmedizin 1991/92. Beitr Infusionsther. Basel. Karger. 1992. vol 30. pp 53–56.
22. Knödler B. Kühnl P: Erste Erfahrungen mil Anti-HCV-Such- und Bestäligungstests der 3. Generation: in Kretschmer V. Stangel W. Eckstein R (Hrsg): Transfusionsmedizin 1992/93. Beitr Infusionsther, Basel, Karger, 1993, vol 31, pp 10–15.
23. Dow BC, Coote I, Munro H, McOmish F, Yap PL, Simmonds P, Follet EAC: Confirmation of hepatitis C virus antibody in blood donors. J Med Virol 1993:41:215–220.
24. Francois M. Dubois F. Brand D. Bacq Y. Guerois C, Mouchel C. Tichet J. Goudeau A, Barin F: Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol 1993:31:1189–1193.
25. Garson JA. Clewley JP. Simmonds P, Zhang LO, Mori J, Ring C, Follett EA, Dow BC, Martin S, Gunson H:Hepatilis C viraentia in United Kingdom blood donors. A multicentre study. Vox Sang 1992: 62:218–223.
26. Aoki SK, Holland PV, Fernando LP, Kuramoto IK, Anderson S, Sazama K, Schoening V, Johnson P, Wilber JC”, Fenner L, Alter HJ: Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C. Blood 1993:82:1000–1005.
27. Aoki SK, Kuramoto IK, Anderson S, Schoening V, Rodriguez R, Fernando L, Sazama K, Holland PV: Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitis. J Viral Hepatitis 1994: 1:73–77.
28. Follett EAC, Dow BC, McOmish F, Yap PL, Hughes W, Mitchell R, Simmonds P: HCV confirmatory testing of blood donors. Lancet 1991:338:1024.
29. Kitchen AD, Barbara JAJ: Epidemiology and prevention: in Zuckerman AJ, Thomas AC (eds): Viral Hepatitis. Scientific Basis and Clinical Management. Edinburgh. Churchill Livingstone. 1993.
30. Caspari G, Beyer J, Richler K, Gerlich WH, Schmitt H: Prevalence of antibodies to recombinant hepatitis C virus protein c100-3 and of elevated transaminase level in blood donors from northern Germany. Med Microbiol Immunol 1991:180:261–272.
31. Tobler LH, Busch MP, Wilber J, Dinello R, Quan S, Polito A, Kochcskv R, Bahl C, Nelles M, Lee SR: Evaluation of indeterminate c-22-3 reactivity in volunteer blood donors. Transfusion 1994:34:130–134.
32. Bresters D, Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, van Exel-Oehlers PJ, van Drimmelen AA, Jansen PL, van der Poel CL, Lelie PN: Recombinant immunoblot reaction patterns and hepatitis C virus RNA in blood donors and non-A. non-B hepatitis patients. Transfusion 1993:33:634–638.
33. Nishimura Y, Yamaguchi K, Williams NP, Takasuki K, Kawano F, Arita I, Imamura Y, Kusumoto Y, Yoshihara N: Antibodies to hepatitis C virus in Japanese blood donors and in hospital personnel. Transfusion 1990:30:667–668.
34. Dittmann S, Roggendorf M, Dürkop J, Wiese M, Lorbeer B, Deinhardt F: Long-term persistence of hepatitis C virus in a single source outbreak. J Hepatol 1991:13:323–327.
35. Cyrus S, Swenson S, Dembowski J: Removal of HCV-infecled donors with use of second generation anti-HCV EIA. Transfusion 1992:32:S134.
36. Bizzaro N, Tremolada F, Casarin C, Bonetti P, Noventa F, Diodati G, Drago C, Realdi G: Serum alanine aminotransferase levels among volunteer blood donors: Effect of sex. alcohol intake and obesity. Hal J Gastroenterol 1992:24:237–241.
37. Lin CK, Chu R, Li KB, Leong S: A study of hepatitis C virus antibodies and serum alanine transferase in blood donors in Hong Kong Chinese. Vox Sang 1992:62:98–101.
38. Romeo R, Thiers V, Driss F, Berthelot P, Nalpas B, Brechot C: 1 lepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. Transfusion 1993:33:629–633.
39. Aguelles O, Janol C: Epidemiology of anti-HCV antibodies in France. Viral I lepatitis Study Group of the French Blood Transfusion Society. Arch Virol 1992:suppl 4:249–252.
40. Sankary TM, Yang G, Romeo JM, Busch M, Vyas GH: Detection of hepatitis B virus and hepatitis C virus in seronegative donors with elevated alanine aminotransferase levels (abstract S223). Transfusion 1993:33(suppl):58S.
41. da Silva Cardoso M, Koerner K, Epple S, Kubanek B: Prevalence of HCV-RNA-posilive blood donors and correlation to ELISA and RIBA status. Ann Hematol 1993;66:147–151.
42. Bukh J, Wanlzin P, Krogsgaard K, Knudsen F, Purcell RH, Miller RH: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Inlect Dis 1993:168:1343–1348.
43. Hilfenhaus J, Krupka U, Nowak T, Cummins LB, Fuchs K, Roggendorf M: Follow-up of hepatitis C virus infection in chimpanzees: Determination of viraemia and specific humoral immune response. J Gen Virol 1992:73:1015–1019.
44. Wolff C, Kleesiek K, Petersen N, Beyer J: Hepatitis C viremia in German blood donors: Serum alanine aminotransferase is not a valid marker for screening. Transfusion 1994:34:361–362.
45. van der Poel CL: Hepatitis C virus. Epidemiology, transmission and prevention: in Reesink HW (ed): Hepatitis C Virus. Curr Stud Hematol Blood Transfusion. Basel. Karger. 1994. No. 61. pp 137–163.